Thursday, September 13, 2012

Mitsubishi Tanabe requests for approval of of MAINTATE (bisoprolol fumarate) in Chronic Atrial Fibrillation

 MAINTATE (bisoprolol fumarate) is a Beta 1 antagonists and provides excellent control of blood pressure and heart rate. The drug is already approved for Hypertension, Arrhythmia and angina pectoris. Upon the request for medical associations, Mitsubishi Tanabe has developed MAINTATE for chronic atrial Fibrillation and an application was filed for this indication.

No comments:

Post a Comment